NCT07793448

Brief Summary

This prospective comparative study evaluated two surgical techniques for residual cavity management following conservative surgery for complicated hepatic cystic echinococcosis. Patients undergoing surgery were managed with either omentoplasty or tube drainage. The study aimed to compare postoperative outcomes between the two techniques, with particular emphasis on postoperative complications and residual cavity-related complications. Long-term follow-up was also performed to assess recurrence and other clinical outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2021

Completed
4.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2026

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 28, 2026

Completed
Last Updated

August 28, 2026

Status Verified

August 1, 2026

Enrollment Period

1.3 years

First QC Date

August 26, 2026

Last Update Submit

August 26, 2026

Conditions

Keywords

Cystic Echinococcosis, Hydatid Cyst, Liver, Omentoplasty, Tube Drainage, Residual Cavity, Conservative Surgery, Biliary Fistula

Outcome Measures

Primary Outcomes (1)

  • Postoperative Residual Cavity-Related Complications

    Incidence of postoperative complications related to the residual hepatic cyst cavity, including residual cavity infection, abscess formation, or other cavity-related complications, compared between the omentoplasty and tube drainage groups.

    Up to 30 days after surgery

Secondary Outcomes (5)

  • Postoperative Bile Leakage

    Up to 30 days after surgery

  • Surgical Site Infection

    Up to 30 days after surgery

  • Overall Postoperative Complications

    Up to 30 days after surgery

  • Operative Time

    During surgery

  • Recurrence of Hepatic Cystic Echinococcosis

    Up to at least 60 months after surgery

Study Arms (2)

Omentoplasty Group

EXPERIMENTAL

Participants underwent conservative surgery for complicated hepatic cystic echinococcosis followed by omentoplasty for residual cavity management.

Procedure: omentoplasty

Tube Drainage Group

ACTIVE COMPARATOR

Participants underwent conservative surgery for complicated hepatic cystic echinococcosis followed by external tube drainage for residual cavity management.

Procedure: External Tube Drainage

Interventions

omentoplastyPROCEDURE

After conservative surgery for complicated hepatic cystic echinococcosis, the residual cavity was obliterated using a pedicled omental flap (omentoplasty) to reduce dead space and cavity-related complications.

Omentoplasty Group

After conservative surgery for complicated hepatic cystic echinococcosis, an external tube drain was placed into the residual cavity for postoperative drainage and monitoring.

Tube Drainage Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-80 years.
  • Complicated hepatic cystic echinococcosis requiring surgical treatment.
  • Cyst diameter ≥8 cm.
  • Cysts located in hepatic segments IV, V, VI, VII, or VIII.
  • WHO-IWGE CE2 or CE3b cyst stage.
  • Presence of at least one complication or high-risk feature, including rupture, adjacent organ involvement, cholangitis, biliary communication, or cyst infection.
  • ASA physical status ≤III.

You may not qualify if:

  • WHO-IWGE CE1 or CE3a cyst stage.
  • Cysts located in hepatic segments I, II, or III.
  • Extensive multiple hepatic cysts.
  • Previous surgery for hepatic cystic echinococcosis.
  • Malignancy.
  • Pregnancy.
  • ASA physical status \>III.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atatürk University Faculty of Medicine

Erzurum, Erzurum, 25240, Turkey (Türkiye)

Location

MeSH Terms

Conditions

EchinococcosisBiliary Fistula

Condition Hierarchy (Ancestors)

Cestode InfectionsHelminthiasisParasitic DiseasesInfectionsDigestive System FistulaDigestive System DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were assigned to two parallel groups undergoing either omentoplasty or tube drainage for residual cavity management following conservative surgery for complicated hepatic cystic echinococcosis.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

August 26, 2026

First Posted

August 28, 2026

Study Start

March 10, 2020

Primary Completion

June 10, 2021

Study Completion

March 10, 2026

Last Updated

August 28, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be publicly shared due to patient confidentiality and ethical considerations. Aggregate study results will be reported in the planned scientific publication.

Locations